Traws Pharma, Inc. 8-K Report: Key Insights for Shareholders (Feb 18, 2025)
Based on the provided XML section from the financial report, here are the key insights:
- Company Identification:
- Entity Name: Traws Pharma, Inc.
- CIK Number: 0001130598
- State of Incorporation: Delaware (DE)
- SEC Central Index Key (CIK): 0001130598
- Employer Identification Number (EIN): 22-3627252
- Address: 12 Penns Trail, Newtown PA 18940
- Phone Number: 267-759-3680
- Filing Information:
- Form Type: 8-K (which is used to report major events that shareholders should know about)
- Filing Date: February 18, 2025
- Stock Information:
- Common Stock Par Value: $0.01 per share
- Ticker Symbol: TRAW
- Exchange: NASDAQ
- Contextual Information:
- Reporting Period: The report is for a single day, specifically February 18, 2025.
- Currency: All amounts are reported in U.S. dollars (USD).
- Units of Measure:
- Financial figures are denominated in USD.
- Additional unit of measure includes shares.
Key Takeaways:
- The report is a significant 8-K filing by Traws Pharma, Inc., reflecting important corporate events or changes, dated February 18, 2025.
- The company is publicly traded on NASDAQ under the ticker TRAW, indicating that it is required to file periodic disclosures with the SEC.
- The par value of the common stock is set at $0.01, which is a standard nominal value for stock issuances, suggesting a possible focus on growth and reinvestment rather than high dividend payouts.
- The document includes identifiers and contact information, indicating transparency and adherence to SEC regulations.
This summary provides a clear understanding of the company's current filing status, stock information, and basic company details.